A Great Stride In PET Imaging, But Not A Panacea – C11 Choline For Diagnosing Recurrent Prostate Cancer

The FDA has approved c11 choline Injection, a Positron Emission Tomography (PET) imaging agent, for use in men to detect prostate cancer recurrences and to locate specific body sites for follow-up tissue sampling, testing and treatment. The indicated use for c11 choline injection is men with elevated prostate specific antigen (PSA) levels after earlier primary [...]

From AUA: ADJUVANT VS. SALVAGE RADIATION THERAPY For Prostate Cancer

On Sunday at the AUA conference there was a poster (#159) titled ADJUVANT VS. SALVAGE RADIATION THERAPY FOLLOWING PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM SEER-MEDICARE written by Keith J. Kowalczyk, etal. The researchers evaluated the optimal timing of external beam radiation (RT) after the completion of a radical prostatectomy (RP) as primary treatment [...]

From the AUA – Treated Positive Surgical Margins Impact Survival

Currently the American Urologic Association is holding their annual conference. Like the ASCO and AACR conferences there are many presentations and posters given that harkens the latest in research findings for general urological topics as well as for prostate cancer. I will be reporting on a number of these findings over the next period of [...]

Carboplatin – A 2nd line chemotherapy?

Carboplatin is a chemotherapy agent used for treatment of many types of cancer. Currently, it is approved by the Food & Drug Administration (FDA) for treating patients with ovarian and non-small cell lung cancer. However, some oncologists use carboplatin “off-label” for other cancers. Commonly, these “off-label” uses include testicular, stomach, and bladder cancers as well [...]

Is Salvage Cryotherapy for Biopsy Proven Recurrent Prostate Cancer An Effective Treatment – Analyzing Disease Free Survival

Following failed radiation therapy (RT) the best treatment of recurrent prostate cancer remains controversial due to the lack of long-term data. Researchers reviewed the survival and establish prognostic indicators for men who received salvage cryotherapy for biopsy-proven recurrent prostate cancer. […]

Go to Top